comparemela.com

Latest Breaking News On - Business results conference - Page 1 : comparemela.com

Protalix BioTherapeutics, Inc (AMEX:PLX) Q3 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen. And welcome to the Protalix Biotherapeutics Third Quarter 2023 Financial and Business Results Conference Call.

United kingdomUnited statesGreat britainEliot forsterBoobalan pachaiyappanJohn vandermostenEyal rubinChuck padalaDror bashanZeev bronfeldEuropean unionProtalix biotherapeutics incMost valuable financial companiesExchange commissionCall transcript novemberBusiness results conference

Protalix BioTherapeutics, Inc (AMEX:PLX) Q1 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics First Quarter 2023 Financial Business Results Conference Call.

New zealandTel avivUnited statesJohn vandermostenDror bashanChuck padalaCharles padalaEyal rubinProtalix biotherapeutics incTel aviv stock exchangeExchange commissionCall transcript mayBusiness results conferenceLifesci advisorsInvestor relationsBusiness update conference

TFF Pharmaceuticals, Inc (TFFP) Q3 2022 Earnings Call Transcript

TFF Pharmaceuticals, Inc. (NASDAQ:NASDAQ:TFFP) Q3 2022 Earnings Conference Call November 14, 2022, 17:00 ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President, CEO.

University of georgiaUnited statesUniversity of texasVernon bernardinoKirk colemanBrad gartnerMichael okunewitchDale christensenBill williamsCorey davisRobert williamsAptar pharmaHarlan weismanJonathan aschoffCompany participantsClinical development group

Protalix BioTherapeutics, Inc (PLX) CEO Dror Bashan on Q1 2022 Results - Earnings Call Transcript

Protalix BioTherapeutics Inc. (NYSE:NYSE:PLX) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Alexandra Schuman - LifeSci Advisors, IR Dror Bashan - President.

United statesUnited kingdomDror bashanJohn vandermostenAlexandra schumanDavid warnockProtalix biotherapeuticEyal rubinExchange commissionProtalix biotherapeutics incZacks small cap researchCompany participantsEuropean medicines agencyUniversity of alabama at birminghamConference call maySci advisors

TFF Pharmaceuticals, Inc (TFFP) CEO Glenn Mattes on Q1 2022 Results - Earnings Call Transcript

TFF Pharmaceuticals, Inc. (NASDAQ:NASDAQ:TFFP) Q1 2022 Earnings Conference Call May 11, 2022, 16:30 ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President, CEO.

United statesUniversity of texasKirk colemanTed rossTed kettererMayank mamtaniDale christensenBill williamsYuan zhiRichard deutschAnthony pogesmaCorey davisAlbert einsteinDaniel carlsonJonathan aschoffLeo serresino

vimarsana © 2020. All Rights Reserved.